| January 2012 | ||||||
|---|---|---|---|---|---|---|
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 13 | 14 | 15 | |
16 | 17 | 21 | 22 | |||
23 | 27 | 28 | 29 | |||
30 | ||||||
| February 2012 | ||||||
|---|---|---|---|---|---|---|
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
4 | 5 | |||||
11 | 12 | |||||
13 | 17 | 18 | 19 | |||
25 | ||||||
| March 2012 | ||||||
|---|---|---|---|---|---|---|
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
3 | 4 | |||||
10 | 11 | |||||
17 | 18 | |||||
24 | 25 | |||||
31 | ||||||
It is LSAM's goal to thoughtfully create networking opportunities directly related to the needs and interests of members while providing an opportunity for Manitoba's life science community to come together as an industry. Additionally, we strive to inform members of events occuring beyond our borders as a means of exploring new partnership and furthering our knowledge.
Want to further your knowledge applying core lean tools?
12-01-2012 Read More
Presented By: Peter Calcott Ph. D. This live, interactive webinar is provided by the Tungsten Shield Group. Most biological, biotechnological and many pharmaceutical s are administered parenterally and therefore must be produced sterile. Since many of these products are heat labile, including biologicals and biotechnology products, they can not be terminally sterilized in their final container but are rather aseptically processed.
18-01-2012 Read More
On Wednesday, January 18th, 2012, LSAM and BCC will give $5,000 in cash to a innovator able to convince a judging panel and room full of people why their innovation is going to make a lot of money. There will be a total of five presenters. Each presenter will have five minutes followed by three questions from the judges, and one from the audience to win the $5,000.
18-01-2012 Read More
On January 19, Neil Fraser, President of Medtronic of Canada Ltd will be guest speaker at the Winnipeg Chamber of Commerce membership luncheon at Fort Garry Place.
19-01-2012 Read More
Sold out - Michael Flaherty, Senior Trade Commissioner, Canadian Consulate in Minneapolis will be visiting Winnipeg from January 18-20, 2012.
20-01-2012 Read More
Presented By: Barry A. Friedman Ph. D. This live, interactive webinar provided by the Tungsten Shield Group. Historically, the absence of clear cGMP requirements for Combination Products has resulted in inconsistent application as to the applicable agency center to submit product for review. Products for both CDER and CBER as the primary Agency contact point may have historically been submitted to the incorrect organization for review because of a lack of knowledge as to the Primary Mode of Action (PMOA) of the product.
24-01-2012 Read More
Non-sterile manufacturing involves issues and challenges many times overlooked in aseptic operations. These include the handling and evaluating of non-sterile components, environments and products. This live, interactive webinar provided by the Tungsten Shield Group.
25-01-2012 Read More
Save the Date! January 26, 2012.
26-01-2012 Read More
Presented By: Barry A. Friedman Ph. D. This live, interactive webinar is provided by the Tungsten Shield Group. In May 2009 the United States Pharmacopeia (USP), revision 32, implemented the long awaited separation of USP General Chapter <61> Microbial Limit Tests into two new chapters, i.e., USP <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration, and USP <62> Microbiological Examination of Nonsterile Products: Tests for Specified Microorganisms.
31-01-2012 Read More
Quality by Design is an FDA initiative that has been in existence for upwards of 8 years.…
05-06-2012 Read More